Evidence map›Paper›PMID 30610118›Full record

ArticleThe Journal of biological chemistry2019

Transforming growth factor β (TGFβ) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation.

Zhikui Liu, Chao Li, Ningling Kang, Harmeet Malhi, Vijay H Shah, Jessica L Maiers

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. FAM134B controls collagen I dynamics in hepatic stellate cell-driven fibrosis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhikui LiuFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905 and.
Chao LiFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905 and.
Ningling KangTumor Microenvironment and Metastasis, Hormel Institute, University of Minnesota, Austin, Minnesota 55912.
Harmeet MalhiFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905 and.ORCID 0000-0002-0882-4990
Vijay H ShahFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905 and.
Jessica L MaiersFrom the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905 and maiers.jessica1@mayo.edu.
Mayo Clinic · USUniversity of Minnesota · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Tamas Ordog · 2009 to 2026
$22.2M
Molecular Mechanisms of Portal HypertensionR01DK059615 · NIDDK · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H. · 2002 to 2023
$6.4M
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVERR01CA160069 · NCI · UNIVERSITY OF MINNESOTA · PI NINGLING KANG · 2011 to 2026
$5.2M
TREAT-MayoU01AA021788 · NIAAA · MAYO CLINIC ROCHESTER · PI MALHI, HARMEET, SHAH, VIJAY H. · 2012 to 2022
$4.7M
Pathobiology of Liver InjuryR01DK111378 · NIDDK · MAYO CLINIC ROCHESTER · PI MALHI, HARMEET · 2016 to 2025
$3.9M
Molecular Mechanisms of Liver Fibrosis (Diversity Supplement)R37AA021171 · NIAAA · MAYO CLINIC ROCHESTER · PI VIJAY H. SHAH · 2019 to 2026
$3.0M
REGULATION OF HEPATIC FIBROGENEISS BY TANGO1K01DK112915 · NIDDK · MAYO CLINIC ROCHESTER · PI MAIERS, JESSICA L · 2018 to 2022
$750k
NCI NIH HHS R01 CA160069NIAAA NIH HHS R37 AA021171NIAAA NIH HHS U01 AA021788NIDDK NIH HHS K01 DK112915NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK059615NIDDK NIH HHS R01 DK111378
6 · The paper itself

Abstract

Transforming growth factor β (TGFβ) potently activates hepatic stellate cells (HSCs), which promotes production and secretion of extracellular matrix (ECM) proteins and hepatic fibrogenesis. Increased ECM synthesis and secretion in response to TGFβ is associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). TGFβ and UPR signaling pathways are tightly intertwined during HSC activation, but the regulatory mechanism that connects these two pathways is poorly understood. Here, we found that TGFβ treatment of immortalized HSCs (

Indexed as

Unfolded Protein ResponseAnimalsCCAAT-Enhancer-Binding Protein-betaE1A-Associated p300 ProteinEndoribonucleasesGene Expression RegulationHepatic Stellate CellsHumansMiceProtein Serine-Threonine KinasesRatsSignal TransductionTransforming Growth Factor betaCCAAT-Enhancer-Binding Protein-betaE1A-Associated p300 ProteinEndoribonucleasesEP300 protein, humanERN1 protein, humanProtein Serine-Threonine KinasesTransforming Growth Factor betaadefovir dipivoxilapoptosis signal-regulating kinase 1 (ASK1)C/EBPβcell signalingc-Jun N-terminal kinase (JNK)collagenendoplasmic reticulum stress (ER stress)fibronectinfibrosisIRE1αp300

Identifiers

PMID30610118
PMCPMC6398135
OpenAlexW2906835496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.